5-23521103-C-T
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_020227.4(PRDM9):c.432C>T(p.Gly144=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 1,614,132 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0075 ( 18 hom., cov: 32)
Exomes 𝑓: 0.00077 ( 21 hom. )
Consequence
PRDM9
NM_020227.4 synonymous
NM_020227.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.698
Genes affected
PRDM9 (HGNC:13994): (PR/SET domain 9) The protein encoded by this gene is a zinc finger protein with histone methyltransferase activity that catalyzes histone H3 lysine 4 trimethylation (H3K4me3) during meiotic prophase. This protein contains multiple domains, including a Kruppel-associated box (KRAB) domain, an SSX repression domain (SSXRD), a PRD1-BF1 and RIZ homologous region, a subclass of SET (PR/SET) domain, and a tandem array of C2H2 zinc fingers. The zinc finger array recognizes a short sequence motif, leading to local H3K4me3, and meiotic recombination hotspot activity. The observed allelic variation alters the DNA-binding sequence specificity of the protein, resulting in distinct meiotic recombination hotspots amongst individuals and populations. Multiple alternate alleles of this gene have been described. [provided by RefSeq, Jul 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
?
Variant 5-23521103-C-T is Benign according to our data. Variant chr5-23521103-C-T is described in ClinVar as [Benign]. Clinvar id is 791624.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
?
Synonymous conserved (PhyloP=0.698 with no splicing effect.
BS1
?
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00752 (1145/152302) while in subpopulation AFR AF= 0.0262 (1088/41556). AF 95% confidence interval is 0.0249. There are 18 homozygotes in gnomad4. There are 509 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
?
High Homozygotes in GnomAd at 18 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRDM9 | NM_020227.4 | c.432C>T | p.Gly144= | synonymous_variant | 6/11 | ENST00000296682.4 | |
PRDM9 | NM_001376900.1 | c.432C>T | p.Gly144= | synonymous_variant | 6/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRDM9 | ENST00000296682.4 | c.432C>T | p.Gly144= | synonymous_variant | 6/11 | 1 | NM_020227.4 | P1 | |
PRDM9 | ENST00000502755.6 | c.432C>T | p.Gly144= | synonymous_variant | 6/11 | 4 | |||
PRDM9 | ENST00000635252.1 | c.255C>T | p.Gly85= | synonymous_variant | 6/11 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.00751 AC: 1143AN: 152184Hom.: 18 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
1143
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00188 AC: 470AN: 249424Hom.: 5 AF XY: 0.00142 AC XY: 192AN XY: 135314
GnomAD3 exomes
AF:
AC:
470
AN:
249424
Hom.:
AF XY:
AC XY:
192
AN XY:
135314
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000767 AC: 1121AN: 1461830Hom.: 21 Cov.: 31 AF XY: 0.000641 AC XY: 466AN XY: 727218
GnomAD4 exome
AF:
AC:
1121
AN:
1461830
Hom.:
Cov.:
31
AF XY:
AC XY:
466
AN XY:
727218
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00752 AC: 1145AN: 152302Hom.: 18 Cov.: 32 AF XY: 0.00684 AC XY: 509AN XY: 74468
GnomAD4 genome
?
AF:
AC:
1145
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
509
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at